Atrial fibrillation, Suprarventricular tachycardia, Atrial flutter, WPWsyndrome
Conditions
Interventions
Catheter ablation for right arterial ganglionated plexi in addition to ablation for WPW syndrome, superaventricular tachycardia or atrial flutter
Catheter ablation for right arterial ganglionated plex
Sponsors
The department of cardiovascular medicine, Chiba university hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who have a plan to be performed catheter ablation to WPW syndrome, atrial flutter, supraventricular tachycardia 2)Patients complicated with atrial fibrillation 3)more than or equal to 20 year old 4)Patients who consented to this clinical trial through the informed consent process in writing of the applicant.
Exclusion criteria
Exclusion criteria: 1)A patient who did not consent to this clinical trial through the informed consent process in writing of the applicant. 2)The case in which the chief complaint is developed by atrial fibrillation. 3)Patients who participate in other clinical trials. 4)Patients who have a plan to be performed catheter ablation to left atrium. 5)Patients who underwent MAZE operation. 6)Atrial fibrillation responsible for the sympathetic nervous system. For example, induced by excise.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence of atrial fibrillation and supraventricular tachycardia | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular events, Administration of antiarrhythmic drugs, Shocks in patients with implantable cardioverter difibrillators | — |
Countries
Japan
Contacts
Public ContactMasayuki Ishimura
Chiba-university hospital The department of cardiovascular medicine
Outcome results
None listed